Creating Cures Through Facility Investments

Pfizer continues to invest in the groundbreaking science and technology needed to discover tomorrow’s life-saving treatments for patients who need them the most. Our research, development, and manufacturing facilities across the country are fostering next-generation healthcare innovation while creating 30,000 U.S.-based jobs.


Our Latest Developments

In 2019, we invested nearly $1 billion in new and existing facilities to fulfill our commitment to deliver breakthroughs that change patients' lives. Our latest investments include:

  • An expansion of our manufacturing facility in Sanford, North Carolina, including a new facility for producing and supplying critical, potentially life-changing gene therapies to patients living with rare diseases around the world.
  • A new, state-of-the-art research and development facility in Chesterfield, Missouri, dedicated to discovering new biologic therapies and vaccines.
  • A new manufacturing facility at our Andover, Massachussetts, campus that produces advanced clinical supplies and accelerates the development of important treatments for patients.

We are committed to investing in first-in-class science that brings thousands of jobs to the American economy and deliver breakthroughs that change patients' lives.

Learn more about some of our other research and development facilities below.